U.S. Retail Distributors Stock News

Biogen's litifilimab (BIIB059) has received FDA Breakthrough Therapy Designation for the treatment of cutaneous lupus erythematosus. The designation is based on Phase 2 trial results that suggest litifilimab may address an unmet medical need in CLE. This status may allow for expedited development and review of the therapy by the FDA. For investors watching NasdaqGS:BIIB, the new designation comes with the stock trading at $179.89 and a 25.0% return over the past year, while longer term...

If you are wondering whether Elevance Health's current share price offers good value or not, it helps to look past the headlines and focus on what the numbers are saying. The stock last closed at US$345.74, with returns of a 6.8% decline over 7 days, a 2.4% decline over 30 days, a 2.4% decline year to date, and a 10.9% decline over 1 year, while the 5 year return sits at 27.2%. Recent news around Elevance Health has centered on broader healthcare policy discussions and insurer sentiment,...

Pfizer agreed to acquire Metsera for $10 billion, aiming to expand into obesity and weight loss drugs. The company is reshaping its R&D focus toward metabolic disease, oncology and immunology. Pfizer signed a licensing deal with Novavax for Matrix M adjuvant technology to support vaccine development. Pfizer (NYSE:PFE), trading around $26.44, is trying to reposition itself after a difficult multi year share price period, with a reported 28.1% decline over 3 years and 2.8% decline over 5...

If you are wondering whether Planet Fitness shares offer good value at current levels, this article walks through what the numbers actually say about the stock. The share price closed at US$91.04, with returns of a 3.6% decline over the last 7 days, 17.0% decline over 30 days, 17.0% decline year to date, 15.8% decline over 1 year, 11.1% gain over 3 years and 17.0% gain over 5 years, which gives a mixed picture for anyone thinking about long term performance. Recent news flow around Planet...

Mondelez International (MDLZ) has put leadership in sharper focus, asking long-time Chief Financial Officer Luca Zaramella to also serve as Chief Operating Officer, centralizing financial and commercial decision making under one experienced executive. See our latest analysis for Mondelez International. The leadership reshuffle comes as the share price trades at US$58.47, with a 1 month share price return of 8.98% and a 1 year total shareholder return of 4.01%, while the 3 year total...

On January 29, 2026, Keysight Technologies and Point2 Technology announced a collaboration to validate Point2’s e-Tube interconnects aimed at easing AI and machine learning data center bottlenecks using Keysight’s high-speed digital test platforms. The partnership highlights how test and measurement expertise can become a critical enabler for hyperscalers seeking lower-power, longer-reach alternatives to traditional copper and optics in xPU clusters. With this AI-focused collaboration in...

Why Perella Weinberg Partners (PWP) is on investors’ radar Perella Weinberg Partners (PWP) has drawn attention after a month return of about 27% and a past 3 months gain of roughly 21%, prompting investors to reassess its advisory driven business and recent financial metrics. See our latest analysis for Perella Weinberg Partners. The recent 30 day share price return of 27.1% and 90 day gain of 20.6% at a latest share price of $22.31 suggest building momentum. This comes alongside a mixed...

If you are wondering whether Viper Energy at around US$42.34 still offers value, you are not alone, especially with energy stocks often moving in sharp cycles. Over the last week the share price return was 6.8%, with a 9.2% return over the past month, although the return over the last year was a 4.3% decline. Recent news flow around Viper Energy has focused on its role as a mineral and royalty interest owner in the Permian Basin and how its asset base ties into broader US oil and gas...

Investors in Meta Platforms, Inc. ( NASDAQ:META ) had a good week, as its shares rose 8.8% to close at US$717 following...

Solos Technology has filed a patent infringement lawsuit against Meta Platforms (NasdaqGS:META) over smart glasses technology. The complaint targets Meta's Ray-Ban smart glasses and claims infringement of multiple Solos patents tied to audio, sensing, and real-time user interaction. Solos is seeking significant damages and an injunction that could affect Meta's wearables business and broader platform plans. The lawsuit also cites alleged internal awareness at Meta of Solos' patents before...

As you might know, Axos Financial, Inc. ( NYSE:AX ) just kicked off its latest quarterly results with some very strong...

Bankwell Financial Group, Inc. ( NASDAQ:BWFG ) last week reported its latest annual results, which makes it a good time...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Citizens...

Sound Financial Bancorp, Inc.'s ( NASDAQ:SFBC ) dividend will be increasing from last year's payment of the same period...

The board of Provident Financial Services, Inc. ( NYSE:PFS ) has announced that it will pay a dividend on the 27th of...

It looks like Franklin Financial Services Corporation ( NASDAQ:FRAF ) is about to go ex-dividend in the next 4 days...

As you might know, West Bancorporation, Inc. ( NASDAQ:WTBA ) last week released its latest full-year, and things did...

The board of First Interstate BancSystem, Inc. ( NASDAQ:FIBK ) has announced that it will pay a dividend of $0.47 per...

Lazard, Inc.'s ( NYSE:LAZ ) investors are due to receive a payment of $0.50 per share on 20th of February. This means...

It's been a good week for Civista Bancshares, Inc. ( NASDAQ:CIVB ) shareholders, because the company has just released...

What are the early trends we should look for to identify a stock that could multiply in value over the long term...

Omega Healthcare Investors (OHI) is back in focus after Wells Fargo cut its rating to Equal Weight and trimmed its target, arguing the REIT’s valuation looks full at current prices for now. See our latest analysis for Omega Healthcare Investors. At a share price of $43.88, Omega Healthcare Investors has seen modest recent moves, with a 4.5% 90 day share price return and a 26.9% 1 year total shareholder return. This indicates that momentum has been building over the longer term despite shorter...

If you are wondering whether KLA's current share price still offers value after a strong run, this article will walk through what the numbers actually say about the stock. Over the last year, KLA returned 95.1%, with a 12.0% gain over the past month but a 5.6% decline in the last week, which may have shifted how investors think about both its upside and risk. Recently, KLA has been in focus as part of broader interest in semiconductor and chip equipment companies, with headlines frequently...

The Board of Directors of The Gorman-Rupp Company recently declared a quarterly cash dividend of US$0.19 per share, payable on March 10, 2026, to shareholders of record as of February 13, 2026. This dividend decision comes alongside evidence of strong multi-year revenue, backlog, and earnings expansion, suggesting the payout is being supported by solid underlying business momentum. Next, we will consider how this combination of a US$0.19 quarterly dividend and robust backlog growth shapes...